ad image

Chemistry, Manufacturing, and Controls

1 / 1
Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform
Leap-In Transposase

Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform

Wheeler Bio

PAO-06-24-CL-05May 30, 2024
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
CMC

Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform

Wheeler Bio

PAO-12-23-CL-04Feb 08, 2024
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Glycosylation

S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach

Junyong Park

Samsung Biologics

PAO-12-23-CL-06Dec 14, 2023
Samsung Biologics
Strategic Partnership

Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies

Samsung Biologics

PR-M10-23-06Oct 24, 2023
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
CMC

The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies

Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.

Wheeler Bio

PAO-07-23-CL-05Jul 26, 2023
Supporting Drug Development – Increasing Probability of Success
Consulting

Supporting Drug Development – Increasing Probability of Success

Nick Davies; Beth Lindsey; Ian Smart

Verta Life Sciences

PAO-03-23-CL-04Mar 24, 2023
State of the Cell and Gene Therapy Market
Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

PAO-10-022-NI-01Oct 11, 2022
Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products
Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Jennifer Cheung

WuXi Advanced Therapies

PAO-09-21-CL-07Sep 14, 2021
Framing the Narrative on CMC Development for Microbiome Therapeutics
Live Biotherapeutic Products

Framing the Narrative on CMC Development for Microbiome Therapeutics

Aaron B. Cowley, Ph.D.; Melanie Cerullo; Jeff Heiser

ReciBioPharm

PAO-06-21-CL-05Jun 14, 2021
Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization
Chemistry, Manufacturing, and Controls

Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization

Matthew Rota; Lisa Caralli; Jim Spavins

Catalent

PAO-01-21-CL-05Feb 05, 2021
1 / 1